Fight not yet over as case against Vertex is dropped after cystic fibrosis medicine price cut

Posted in: Access to Medicines, Healthcare system, Latest

Last year a South African woman took a multibillion-dollar United States pharmaceutical company to court with the aim of securing access to life-changing cystic fibrosis medicines. That case has now been dropped following a reduction in the price charged for the medicines in South Africa. Catherine Tomlinson reports.

Fight not yet over as case against Vertex is dropped after cystic fibrosis medicine price cut

Interview: Cheri Nel, the investment banker from Joburg taking on pharma over cystic fibrosis medicines

Posted in: Access to Medicines, Healthcare system, Latest

Johannesburg-based investment banker Cheri Nel is the driving force behind a court case that may result in dramatically expanded access to life-changing new cystic fibrosis (CF) medicines. Biénne Huisman asked Nel about the motivation behind the court case and what it is like to live with CF.